Atara Biotherapeutics, Inc. (ATRA) stock
ATRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.50+0.10 (+1.56%)
Close on Nov 17, 2026Market cap $65.25MP/E –Yield –
Atara Biotherapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Atara Biotherapeutics's market cap was $77.72M on Nov 11, 2026, against $108.87M a year earlier. Over the last 5 years it ranged from $34.64M to $1.39B, with a median of $84.08M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $77.72M | -40.4% |
| 2025 | Dec 31, 2025 | $130.43M | +70.7% |
| 2024 | Dec 31, 2024 | $76.40M | +46.2% |
| 2023 | Dec 29, 2023 | $52.27M | -83.2% |
| 2022 | Dec 30, 2022 | $311.20M | -77.7% |
| 2021 | Dec 31, 2021 | $1.39B | -8.1% |
| 2020 | Dec 31, 2020 | $1.52B | +70.0% |
| 2019 | Dec 31, 2019 | $891.44M | -43.8% |
| 2018 | Dec 31, 2018 | $1.59B | +286201.1% |
| 2017 | Dec 29, 2017 | $553.86K | -99.9% |
| 2016 | Dec 30, 2016 | $409.56M | -45.3% |
| 2015 | Dec 31, 2015 | $748.09M | +1752.4% |
| 2014 | Dec 31, 2014 | $40.38M | – |
See a number that looks wrong?